• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项基于犹他州人群的为期20年的腹泻后溶血性尿毒症综合征研究。

A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah.

作者信息

Siegler R L, Pavia A T, Christofferson R D, Milligan M K

机构信息

Division of Nephrology, University of Utah School of Medicine, Salt Lake City 84132.

出版信息

Pediatrics. 1994 Jul;94(1):35-40.

PMID:8008534
Abstract

OBJECTIVE

To determine epidemiologic features, trends in frequency, and predictors of clinical outcome of postdiarrheal hemolytic uremic syndrome (HUS) in Utah.

DESIGN

A 20-year population-based study of HUS with a review of the HUS registry, hospital records, transplant registry, and a survey of pediatricians and pediatric nephrologists to ensure completeness of ascertainment.

POPULATION

All Utah residents under 18 years of age with HUS occurring after a diarrheal prodrome between 1971 and 1990.

OUTCOME MEASURES

Incidence of HUS, severity, complications, and long-term sequelae.

RESULTS

There were 157 cases during 20 years; 140 (89%) occurred after a diarrheal prodrome. The mean annual incidence was 1.42/100,000 children (range 0.2 to 3.4/100,000 children/year). Periods of high incidence occurred; however, there was no overall sustained increase in incidence. Escherichia coli O157:H7 was isolated from the stool of 62% of children who had specimens submitted. There were no differences between the first and second decade in the proportion with diarrheal prodrome, bloody diarrhea, most abnormal laboratory values, hospital course, or outcome. However, admission laboratory abnormalities were more severe during the first decade suggesting a delay in diagnosis. Age < 2 years, anuria before admission, and higher white blood cell counts on admission predicted severe disease. Bad outcome (death, end-stage renal disease, or stroke) occurred in 11%; 5% died. Chronic renal sequelae, usually mild, were found on follow-up (median 6.5 years) in 51% of survivors.

CONCLUSIONS

HUS has been an important clinical and public health problem in Utah for 20 years. The consistency of the clinical and epidemiologic features over 2 decades suggests that a common etiologic agent has accounted for most cases of HUS in this region since 1971.

摘要

目的

确定犹他州腹泻后溶血尿毒综合征(HUS)的流行病学特征、发病率趋势及临床结局的预测因素。

设计

一项基于人群的20年HUS研究,回顾HUS登记处、医院记录、移植登记处,并对儿科医生和儿科肾病学家进行调查以确保确诊的完整性。

研究对象

1971年至1990年间,所有18岁以下腹泻前驱症状后发生HUS的犹他州居民。

观察指标

HUS发病率、严重程度、并发症及长期后遗症。

结果

20年间共157例;140例(89%)发生于腹泻前驱症状后。年平均发病率为1.42/10万儿童(范围0.2至3.4/10万儿童/年)。有高发期;但发病率无总体持续上升。62%送检标本的儿童粪便中分离出大肠杆菌O157:H7。腹泻前驱症状、血性腹泻、多数异常实验室值、住院病程或结局在第一个十年和第二个十年间无差异。然而,第一个十年入院时实验室异常更严重,提示诊断延迟。年龄<2岁、入院前无尿及入院时白细胞计数较高提示病情严重。不良结局(死亡、终末期肾病或中风)发生率为11%;5%死亡。随访(中位时间6.5年)发现51%幸存者有慢性肾脏后遗症,通常较轻。

结论

20年来,HUS一直是犹他州重要的临床和公共卫生问题。20年间临床和流行病学特征的一致性表明,自1971年以来,一种常见病原体导致了该地区大多数HUS病例。

相似文献

1
A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah.一项基于犹他州人群的为期20年的腹泻后溶血性尿毒症综合征研究。
Pediatrics. 1994 Jul;94(1):35-40.
2
Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.大肠杆菌O157:H7感染期间的相对肾脏保护作用:与静脉补液扩容的关系
Pediatrics. 2005 Jun;115(6):e673-80. doi: 10.1542/peds.2004-2236.
3
The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota.明尼苏达州溶血尿毒综合征的流行病学及临床特征
N Engl J Med. 1990 Oct 25;323(17):1161-7. doi: 10.1056/NEJM199010253231703.
4
Hemolytic Uremic Syndrome After an Escherichia coli O111 Outbreak.大肠杆菌O111暴发后出现的溶血性尿毒综合征
Arch Intern Med. 2010 Oct 11;170(18):1656-63. doi: 10.1001/archinternmed.2010.346.
5
[Hemolytic uremic syndrome in children of Mendoza, Argentina: association with Shiga toxin-producing Escherichia coli infection].[阿根廷门多萨儿童溶血尿毒综合征:与产志贺毒素大肠杆菌感染的关联]
Medicina (B Aires). 1998;58(1):1-7.
6
Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006.1996 - 2006年法国15岁以下儿童溶血尿毒综合征监测:一个监测O157和非O157产志贺毒素大肠杆菌感染的系统
Pediatr Infect Dis J. 2008 Jul;27(7):595-601. doi: 10.1097/INF.0b013e31816a062f.
7
A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina.阿根廷图库曼地区溶血尿毒综合征患儿的临床与细菌学研究。
Jpn J Infect Dis. 1999 Apr;52(2):33-7.
8
[Post-diarrheal haemolytic uremic syndrome: when shall we consider it? Which follow-up?].[腹泻后溶血性尿毒症综合征:何时应予以考虑?如何进行随访?]
Arch Pediatr. 2011 Jul;18(7):823-30. doi: 10.1016/j.arcped.2011.04.001. Epub 2011 May 14.
9
Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.1997 - 2000年德国和奥地利儿童溶血尿毒综合征中产生志贺毒素大肠杆菌感染的临床病程及作用:一项前瞻性研究
J Infect Dis. 2002 Aug 15;186(4):493-500. doi: 10.1086/341940. Epub 2002 Aug 2.
10
Albuminuria and estimated GFR 5 years after Escherichia coli O157 hemolytic uremic syndrome: an update.大肠杆菌O157溶血尿毒综合征5年后的蛋白尿和估算肾小球滤过率:最新情况
Am J Kidney Dis. 2008 Mar;51(3):435-44. doi: 10.1053/j.ajkd.2007.10.042.

引用本文的文献

1
Interventions for preventing diarrhoea-associated haemolytic uraemic syndrome.预防腹泻相关性溶血尿毒综合征的干预措施。
Cochrane Database Syst Rev. 2025 Apr 25;4(4):CD012997. doi: 10.1002/14651858.CD012997.pub3.
2
A novel Shiga toxin 2a neutralizing antibody therapeutic with low immunogenicity and high efficacy.一种新型的具有低免疫原性和高效力的志贺毒素 2a 中和抗体治疗药物。
Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0059823. doi: 10.1128/aac.00598-23. Epub 2023 Dec 4.
3
Factors affecting dialysis duration in children with Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome.
产志贺毒素大肠杆菌相关性溶血尿毒综合征患儿透析时间的影响因素。
Pediatr Nephrol. 2023 Aug;38(8):2753-2761. doi: 10.1007/s00467-022-05839-0. Epub 2023 Jan 27.
4
Trends and Outcomes of Hospitalizations Due to Hemolytic Uremic Syndrome: A National Perspective.溶血尿毒综合征住院治疗的趋势与结果:全国视角
Cureus. 2022 Dec 8;14(12):e32315. doi: 10.7759/cureus.32315. eCollection 2022 Dec.
5
Interventions for preventing diarrhoea-associated haemolytic uraemic syndrome.预防腹泻相关性溶血尿毒综合征的干预措施。
Cochrane Database Syst Rev. 2021 Jul 5;7(7):CD012997. doi: 10.1002/14651858.CD012997.pub2.
6
Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.志贺毒素相关性溶血尿毒综合征:成人患者的特点及对重症监护管理的影响。
Toxins (Basel). 2021 Apr 26;13(5):306. doi: 10.3390/toxins13050306.
7
Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.志贺毒素相关性溶血尿毒综合征:一篇叙述性综述。
Toxins (Basel). 2020 Jan 21;12(2):67. doi: 10.3390/toxins12020067.
8
A simple prognostic index for Shigatoxin-related hemolytic uremic syndrome at onset: data from the ItalKid-HUS network.Shigatoxin 相关溶血尿毒综合征发病时的简易预后指标:来自 ItalKid-HUS 网络的数据。
Eur J Pediatr. 2018 Nov;177(11):1667-1674. doi: 10.1007/s00431-018-3198-7. Epub 2018 Aug 10.
9
Enterohemorrhagic colitis with disseminated intravascular coagulation.出血性结肠炎伴弥散性血管内凝血
Proc (Bayl Univ Med Cent). 2018 May 14;31(3):319-320. doi: 10.1080/08998280.2018.1463776. eCollection 2018 Jul.
10
Clinical and Laboratory Predictors of Shiga Toxin-Producing Escherichia coli Infection in Children With Bloody Diarrhea.儿童血样腹泻中产志贺毒素大肠杆菌感染的临床和实验室预测因子。
J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):e116-e122. doi: 10.1093/jpids/piy025.